Pancreatic Cancer Research

ResearcherTaizhou Municipal HospitalActive in the last 2 years

Xianfei Zhou

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5053442044. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 5 papers · 2026: 1 paper

Papers 7

  1. ITGB4 Activates the Pentose Phosphate Pathway to Reduce the Sensitivity of Pancreatic Adenocarcinoma to Gemcitabine. Co-author DOI 10.1097/mpa.0000000000002690↗
  2. Neferine induces cell growth inhibition and apoptosis via ROS-mediated activation of p38 in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1007/s10735-025-10547-8↗
  3. HIF-3α Facilitates the Proliferation and Migration in Pancreatic Cancer by Inhibiting Autophagy Through Downregulating TP53INP2. Co-author DOI 10.1007/s12013-024-01624-y↗
  4. Hypoxia-induced autophagy in pancreatic cancer counteracts the cytotoxicity of CD8+ T cells by inhibiting the expression of MHC-I. Co-author DOI 10.1038/s41435-024-00315-1↗
  5. Establishment of a prognostic model for pancreatic cancer based on vesicle-mediated transport protein-related genes. Last author DOI 10.1080/10255842.2024.2367739↗
  6. ITGB4/BNIP3 Activates Autophagy and Reduces MHC-I Expression to Mediate Tumour Immune Escape in Pancreatic Cancer Cell Lines. Co-author DOI 10.1111/imm.13890↗
  7. HIF-3α Promotes Metastatic Phenotypes in Pancreatic Cancer by Transcriptional Regulation of the RhoC-ROCK1 Signaling Pathway. Co-author DOI 10.1158/1541-7786.mcr-17-0256↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Renwei Xing · 4 shared papers, 2025 · strength 1.18
  2. Fan Yang · 3 shared papers, 2025 · strength 0.91
  3. Xianwu Xia · 1 shared paper, 2026 · strength 0.39
  4. Yanfang Cao · 1 shared paper, 2025 · strength 0.33
  5. Siyuan Liang · 1 shared paper, 2025 · strength 0.30
  6. Yong Lan · 1 shared paper, 2025 · strength 0.30
  7. Hanqiu Nie · 1 shared paper, 2025 · strength 0.28
  8. Xingjun Guo · 1 shared paper, 2018 · strength 0.11
  9. Meiyuan Chen · 1 shared paper, 2018 · strength 0.11
  10. Jianxin Jiang · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.